Bot Image’s prostate MRI AI software wins new clearance
SaveSavedRemoved 0
[ad_1]
The firm had received its initial FDA clearance in 2022 for the use of ProstatID in detection and diagnosis of prostate cancer on MRI. With the new additional clearance, ProstatID can also be used in prostate cancer screening on MRI and biparametric MRI, according to the vendor.
Copyright © 2023 AuntMinnie.com
[ad_2]
Go to publisher site for the complete article:
Read More
